These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 18712711)

  • 1. Tissue culture-based breast cancer biomarker discovery platform.
    Kulasingam V; Diamandis EP
    Int J Cancer; 2008 Nov; 123(9):2007-12. PubMed ID: 18712711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cancer cell secretome: a good source for discovering biomarkers?
    Pavlou MP; Diamandis EP
    J Proteomics; 2010 Sep; 73(10):1896-906. PubMed ID: 20394844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An integrated cell line-based discovery strategy identified follistatin and kallikrein 6 as serum biomarker candidates of breast carcinoma.
    Mangé A; Dimitrakopoulos L; Soosaipillai A; Coopman P; Diamandis EP; Solassol J
    J Proteomics; 2016 Jun; 142():114-21. PubMed ID: 27168011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges and opportunities for cell line secretomes in cancer proteomics.
    Méndez O; Villanueva J
    Proteomics Clin Appl; 2015 Apr; 9(3-4):348-57. PubMed ID: 25418557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical proteomics in breast cancer: a review.
    Gast MC; Schellens JH; Beijnen JH
    Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer biomarkers: proteomic discovery and translation to clinically relevant assays.
    Chung L; Baxter RC
    Expert Rev Proteomics; 2012 Dec; 9(6):599-614. PubMed ID: 23256671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretome proteomics for discovery of cancer biomarkers.
    Makridakis M; Vlahou A
    J Proteomics; 2010 Nov; 73(12):2291-305. PubMed ID: 20637910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical proteomics and breast cancer: strategies for diagnostic and therapeutic biomarker discovery.
    Bertucci F; Goncalves A
    Future Oncol; 2008 Apr; 4(2):271-87. PubMed ID: 18407739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic analysis of conditioned media from the PC3, LNCaP, and 22Rv1 prostate cancer cell lines: discovery and validation of candidate prostate cancer biomarkers.
    Sardana G; Jung K; Stephan C; Diamandis EP
    J Proteome Res; 2008 Aug; 7(8):3329-38. PubMed ID: 18578523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New trends in molecular biomarker discovery for breast cancer.
    Radpour R; Barekati Z; Kohler C; Holzgreve W; Zhong XY
    Genet Test Mol Biomarkers; 2009 Oct; 13(5):565-71. PubMed ID: 19814613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass spectrometry-based proteomics: the road to lung cancer biomarker discovery.
    Indovina P; Marcelli E; Pentimalli F; Tanganelli P; Tarro G; Giordano A
    Mass Spectrom Rev; 2013; 32(2):129-42. PubMed ID: 22829143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glioma proteomics: status and perspectives.
    Niclou SP; Fack F; Rajcevic U
    J Proteomics; 2010 Sep; 73(10):1823-38. PubMed ID: 20332038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomics discovery of radioresistant cancer biomarkers for radiotherapy.
    Chang L; Graham P; Hao J; Bucci J; Malouf D; Gillatt D; Li Y
    Cancer Lett; 2015 Dec; 369(2):289-97. PubMed ID: 26427840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical proteomics and breast cancer.
    Zeidan BA; Townsend PA; Garbis SD; Copson E; Cutress RI
    Surgeon; 2015 Oct; 13(5):271-8. PubMed ID: 25736469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated pipeline for mass spectrometry-based discovery and confirmation of biomarkers demonstrated in a mouse model of breast cancer.
    Whiteaker JR; Zhang H; Zhao L; Wang P; Kelly-Spratt KS; Ivey RG; Piening BD; Feng LC; Kasarda E; Gurley KE; Eng JK; Chodosh LA; Kemp CJ; McIntosh MW; Paulovich AG
    J Proteome Res; 2007 Oct; 6(10):3962-75. PubMed ID: 17711321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel prognostic protein markers of resectable pancreatic cancer identified by coupled shotgun and targeted proteomics using formalin-fixed paraffin-embedded tissues.
    Takadate T; Onogawa T; Fukuda T; Motoi F; Suzuki T; Fujii K; Kihara M; Mikami S; Bando Y; Maeda S; Ishida K; Minowa T; Hanagata N; Ohtsuka H; Katayose Y; Egawa S; Nishimura T; Unno M
    Int J Cancer; 2013 Mar; 132(6):1368-82. PubMed ID: 22915188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective.
    Findeisen P; Neumaier M
    Clin Chem Lab Med; 2009; 47(6):666-84. PubMed ID: 19445650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
    Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
    J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Validation of a Novel Plasma Protein Signature for Breast Cancer Diagnosis by Using Multiple Reaction Monitoring-based Mass Spectrometry.
    Lee HB; Kang UB; Moon HG; Lee J; Lee KM; Yi M; Park YS; Lee JW; Yu JH; Choi SH; Cho SH; Lee C; Han W; Noh DY
    Anticancer Res; 2015 Nov; 35(11):6271-9. PubMed ID: 26504062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Proteomics and biomarkers for detection of cervical cancer].
    Kacerovský M; Tosner J
    Ceska Gynekol; 2009 Oct; 74(5):335-8. PubMed ID: 20063836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.